摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4S)-3-(2-aminopyrimidin-4-yl)-4-propan-2-yl-1,3-oxazolidin-2-one

中文名称
——
中文别名
——
英文名称
(4S)-3-(2-aminopyrimidin-4-yl)-4-propan-2-yl-1,3-oxazolidin-2-one
英文别名
——
(4S)-3-(2-aminopyrimidin-4-yl)-4-propan-2-yl-1,3-oxazolidin-2-one化学式
CAS
——
化学式
C10H14N4O2
mdl
——
分子量
222.24
InChiKey
PCUALPVSTBQJHM-SSDOTTSWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    81.3
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH
    申请人:VESTAS WIND SYSTEMS A/S
    公开号:US20140235620A1
    公开(公告)日:2014-08-21
    The invention is directed to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 -R 6 are defined herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.
    该发明涉及公式(I)的化合物或其药用盐,其中R1-R6在此处定义。该发明还涉及含有公式(I)化合物的组合物,以及利用这些化合物抑制具有新型活性的突变IDH蛋白。该发明还涉及利用公式(I)的化合物治疗与这些突变IDH蛋白相关的疾病或紊乱,包括但不限于细胞增殖紊乱,如癌症。
  • Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof
    申请人:IsoCure Biosciences Inc.
    公开号:US11149032B2
    公开(公告)日:2021-10-19
    The invention provides novel chemical compounds useful for treating cancer, or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
    本发明提供了可用于治疗癌症或相关疾病或紊乱的新型化合物,以及药物组合物及其制备和使用方法。
  • INHIBITORS OF MUTANT ISOCITRATE DEHYDROGENASES AND COMPOSITIONS AND METHODS THEREOF
    申请人:IsoCure Biosciences Inc.
    公开号:US20200071309A1
    公开(公告)日:2020-03-05
    The invention provides novel chemical compounds useful for treating cancer, or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
  • US8957068B2
    申请人:——
    公开号:US8957068B2
    公开(公告)日:2015-02-17
查看更多